Role of Monoclonal Antibody "Alemtuzumab" in the Treatment of Multiple Sclerosis

This article will review current treatment options for multiple sclerosis (MS) while keeping our primary focus on alemtuzumab, as it is now approved in more than 65 countries. From a pathophysiological point of view, MS is a disabling disease impacting a patient's life both physically and menta...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Cureus
Hlavní autoři: Nosher, Sadia, Fuad, Sehrish, Mishra, Nupur, Alrashid, Zaid A, Rathod, Bindu, Mohan, Devyani, Basavanagowda, Deepak M, Kaur, Arveen, Heindl, Stacey E
Médium: Artigo
Jazyk:Inglês
Vydáno: Cureus 2021
Témata:
Family/General Practice
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7948316/
https://ncbi.nlm.nih.gov/pubmed/33728194
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7759/cureus.13246
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky